Skip to main content

Abbott predicts fewer sales of COVID-19 tests in 2022 but says the business of at-home tests isn’t going away

Abbott Laboratories made $3.3 billion in revenue from its COVID-19 tests in the first three months of the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.